The “checkpoint” in the proposed theory, i.e., the establishment of immune tolerance via the immune checkpoint, may open the way for an immune checkpoint blockade by targeting PD-1/PD-L1 or other molecules in the treatment of endometriosis. The gene discussed is CD274; the disease is endometriosis.